Calf circumference predicts sarcopenia and all‐cause mortality in older patients undergoing maintenance hemodialysis: A prospective cohort study
Nutrition in Clinical Practice · 2026
DOI: 10.1002/ncp.11337 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrition in Clinical Practice, 2026. Verfasst von Yan Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Sarcopenia, Renal Dialysis, Leg. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Fund of Guizhou Provincial People's Hospital; Guizhou Science and Technology Co-support, The field of social development (2780); and Guizhou Science and….
Abstract (Originalsprache)
Background
The role of calf circumference (CC) in predicting sarcopenia and mortality of patients undergoing maintenance hemodialysis (MHD) remains debated. This study assessed CC's predictive value, optimal threshold, and mortality association in older patients undergoing MHD.
Methods
An observational cohort study was conducted on older adult patients undergoing MHD. Sarcopenia was defined by European Working Group on Sarcopenia in Older People. Logistic regression and receiver operating characteristic (ROC) analysis were used to explore the relationship between CC and sarcopenia. Kaplan‐Meier and Cox regression analyses assessed survival over 2 years.
Results
A total of 979 older adult patients undergoing MHD treatment, with an average age of 73.4 years, were included in this study. The prevalence of sarcopenia was 61.1%. Male sex (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.04–0.45; P = 0.017) and CC (OR, 0.38; 95% CI, 0.26–0.56; P < 0.001) were identified as independent risk factors for sarcopenia through multifactorial logistic regression analysis. ROC curves for CC and sarcopenia indicated that the optimal cutoff value for men was 32.5 cm (area under the curve [AUC], 0.904; sensitivity, 0.958; specificity, 0.841), whereas for women, it was 31.9 cm (AUC, 0.884; sensitivity, 0.922; specificity: 0.756). Kaplan‐Meier survival analysis demonstrated lower survival probabilities in patients with sarcopenia and low CC. After adjustment for multiple factors, Cox regression analysis revealed that patients in the sarcopenia group (hazard ratio [HR] = 2.411; P = 0.017) and those in the low‐CC group (HR = 2.045; P = 0.046) had significantly shorter overall survival.
Conclusions
CC is an independent predictor of sarcopenia and mortality in older patients undergoing MHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
- Graduate School, Zunyi Medical University, Zunyi, Guizhou, China.
ORCID-Profile: Yan Shen
Förderung
- Youth Fund of Guizhou Provincial People's Hospital; Guizhou Science and Technology Co-support, The field of social development (2780); and Guizhou Science and…
Zitieren
APA
Shen, Y., Qin, H., Liu, X., Liu, L., Chen, S., Yang, Y., Yuan, J., & Zha, Y. (2026). Calf circumference predicts sarcopenia and all‐cause mortality in older patients undergoing maintenance hemodialysis: A prospective cohort study. Nutrition in Clinical Practice. https://doi.org/10.1002/ncp.11337
Vancouver
Shen Y, Qin H, Liu X, Liu L, Chen S, Yang Y, et al. Calf circumference predicts sarcopenia and all‐cause mortality in older patients undergoing maintenance hemodialysis: A prospective cohort study. Nutrition in Clinical Practice. 2026. doi:10.1002/ncp.11337
BibTeX
@article{Shen2026,
author = {Shen, Yan and Qin, Hongmin and Liu, Xiaosu and Liu, Lu and Chen, Shuang and Yang, Yuqi and Yuan, Jing and Zha, Yan},
title = {Calf circumference predicts sarcopenia and all‐cause mortality in older patients undergoing maintenance hemodialysis: A prospective cohort study},
journal = {Nutrition in Clinical Practice},
year = {2026},
doi = {10.1002/ncp.11337}
}
EUVIMED